Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor.
Clin Pharmacokinet
; 52(2): 139-51, 2013 Feb.
Article
em En
| MEDLINE
| ID: mdl-23248072
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxidiazóis
/
Inibidores Enzimáticos
/
Inibidores de Catecol O-Metiltransferase
/
Antiparkinsonianos
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article